Cargando…
535. Risk Factors for Seeking Medical Care Following Monoclonal Antibody Treatment For COVID-19
BACKGROUND: The FDA issued emergency use authorization for neutralizing monoclonal antibodies (mAb) for the treatment of mild-moderate coronavirus disease 2019 (COVID-19) in patients who were at high risk of disease progression. METHODS: In this case-control study, we assessed risk factors for patie...
Autores principales: | MALIK, I S M A I L O, Szpunar, Susan M, Salaytah, Natali, Bhargava, Ashish, Sharma, Mamta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679425/ http://dx.doi.org/10.1093/ofid/ofad500.604 |
Ejemplares similares
-
511. Risk Factors for Seeking Medical Care Following Nirmatrelvir-Ritonavir (Paxlovid) Treatment For COVID-19
por: Bhargava, Ashish, et al.
Publicado: (2023) -
636. Epidemiology and Outcome Among the Elderly Hospitalized Patients with Respiratory Syncytial Virus Infections
por: Bhargava, Ashish, et al.
Publicado: (2023) -
2611. Risk Factors Associated with Longer Hospital Stay in Adult Patients with Respiratory Syncytial Virus Infections
por: Bhargava, Ashish, et al.
Publicado: (2023) -
635. Morbidity and Mortality Associated with Respiratory Syncytial Virus Infections Among the Adult Hospitalized Patients
por: Bhargava, Ashish, et al.
Publicado: (2023) -
451. Is Antibody to Nucleocapsid More Prevalent in Individuals with Severe COVID-19?
por: Patel, Hemang, et al.
Publicado: (2021)